Title : RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia.

Pub. Date : 1990 Sep 15

PMID : 2205309






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Eighty percent of the mutations involved substitution of aspartic acid for glycine (G----A) in the 12th or 13th codons of N-ras or K-ras. Aspartic Acid KRAS proto-oncogene, GTPase Homo sapiens